<DOC>
	<DOCNO>NCT01041716</DOCNO>
	<brief_summary>Carbapenems class antibiotic agent kill broad spectrum bacteria . Infections due gram-negative bacteria acquire resistance carbapenems increase , especially Klebsiella pneumoniae , Acinetobacter baumannii Pseudomonas aeruginosa . The optimal treatment infection know . Antibiotics like polymyxin , tigecycline rifampin use alone combination antibiotic . The outcome use new old drug well study . This observational study aim study clinical microbiological outcome infection treatment institution .</brief_summary>
	<brief_title>Clinical Microbiological Outcomes Infections Due Carbapenem-Resistant Gram-Negative Bacteria</brief_title>
	<detailed_description>Objectives 1 . To define demographic risk factor profile patient acquire CRGNB infection . 2 . To define characteristic CRGNB infection . 3 . To report different treatment employ CRGNB infection . 4 . To report microbiological clinical outcome different treatment option - a. Microbiological outcome : frequency microbiological success . Microbiological success define two successive negative culture site CRGNB originally isolate . - b . Clinical outcome : clinical success ( clinical cure ) , adverse effect treatment especially nephrotoxicity relation use polymyxin , ICU length stay ( applicable ) , hospital length stay , ICU mortality ( applicable ) , hospital mortality in-hospital recurrence infection . Clinical success define resolution improvement clinical symptom sign infection discontinuation antibiotic . Study duration : We plan collect data one year period . Based current prevalence rate institution , anticipate data 300 patient .</detailed_description>
	<criteria>Adult inpatient ( ageâ‰¥18 year ) infection due CRGNB ( Klebsiella pneumoniae , Acinetobacter baumannii Pseudomonas aeruginosa ) . CRGNB Infection define isolation CRGNB source require treatment antiinfective agent without manifestation systemic inflammatory response syndrome . Patients colonize CRGNB active infection . Recurrent infection previously include patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Carbapenem</keyword>
	<keyword>Klebsiella pneumoniae carbapenemase</keyword>
	<keyword>Acinetobacter baumannii</keyword>
	<keyword>Pseudomonas aeruginosa</keyword>
</DOC>